Cardiome Pharma Names Jennifer Archibald As CFO

Cardiome Pharma Q4 12 Earnings Conference Call At 8:15 AM ET

Trade CRME now with

9/20/2012 8:10 PM ET

Cardiome Pharma Corp. (CRME: Quote, COM.TO) on Thursday announced the appointment Jennifer Archibald as chief financial officer, in place of Curtis Sikorsky, who has resigned from the position.Sikorsky will continue to serve the company in a consulting capacity during the transition.

Cardiome Pharma Interim CEO William Hunter said, "We are delighted to have Jennifer join the Cardiome executive management team. Over the past six years, Jennifer has proven herself to be a highly capable senior finance leader."

Jennifer has worked for 15 years in both public and private companies, and has been Cardiome's Director of Finance for the past six years. Prior to joining Cardiome, Jennifer managed the accounting operations at the corporate office of The Jim Pattison Group and was earlier a corporate auditor with KPMG.

Shares of Cardiome Pharma closed at $0.35 down 1 cent or 2.72% on the Nasdaq. On the TSX, the stock closed at C$0.34.

Click here to receive FREE breaking news email alerts for Cardiome Pharma Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

<<Previous 81 Articles

Editors Pick

Germany Skirts Recession In Q1 As Consumer Spending Recovers

A rebound in consumer spending helped the German economy thwart recession in the first quarter of 2013, detailed data from the Federal Statistical Office revealed Friday. However, the continued fall in firms' fixed asset investment and extreme weather conditions stifled the recovery. Market research group GfK predicts further increase in consumer confidence in June.

Gap Profit Climbs 43%

Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate.

Stocks Close Modestly Lower But Well Off Worst Levels - U.S. Commentary

After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red.